NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.8 AUD | +2.16% |
|
+8.46% | -12.70% |
| May. 09 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
| Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Other Pharmaceuticals | +2.16% | +8.46% | -12.70% | +53.52% | +2,047.78% | 1.82B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NEU Stock
- Charts Neuren Pharmaceuticals Limited
- Comparison Chart